Merkel Cell Carcinoma: 30-Year Experience from a Single Institution

  title={Merkel Cell Carcinoma: 30-Year Experience from a Single Institution},
  author={Juan A. Santamaria-Barria and PhD Genevieve M. Boland and Beow Y. Yeap ScD and Valentina Nardi and Dora C Dias-Santagata and James C. Cusack},
  journal={Annals of Surgical Oncology},
Merkel cell carcinoma (MCC) is a rare cutaneous malignancy. Few single-institution series have been reported. Review of MCC patients treated at our institution between 1980 and 2010. Patient, tumor, and treatment variables were analyzed to determine MCC-specific outcomes. We identified 161 patients with MCC. There was a 2.5-fold increase in cases over the last decade. Median length of follow-up was 36 months. Stage at diagnosis was I in 35 %, II in 21 %, IIIa in 12 %, IIIb in 23 %, and IV in 9… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 35 extracted citations

Malignancies of the Groin

Springer International Publishing • 2018
View 20 Excerpts
Highly Influenced

Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy

Annals of oncology : official journal of the European Society for Medical Oncology • 2017
View 1 Excerpt

Immune Checkpoint Inhibition in Cancers that Affect the Head and Neck.

International journal of radiation oncology, biology, physics • 2017
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 59 references

Features predicting sentinel lymph node positivity in Merkel cell carcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2011
View 1 Excerpt

Similar Papers

Loading similar papers…